Protalix BioTherapeutics (PLX) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.17 +0.46%
Revenue Growth %: -49.8%
Financial Fact:
OPERATING LOSS: -6.65M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -49.8%
Financial Fact:
OPERATING LOSS: -6.65M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.03). Revenue for the quarter came in at $13.47 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- Alphabet to replace Verizon in the Dow Jones Industrial Average
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
